Entering text into the input field will update the search result below

Kiniksa Pharmaceuticals (KNSA) CEO, Sanj Patel on Q3 2021 Results - Earnings Call Transcript

Nov. 01, 2021 11:50 AM ETKiniksa Pharmaceuticals, Ltd. (KNSA)
SA Transcripts profile picture
SA Transcripts

Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) Q3 2021 Earnings Conference Call November 1, 2021 8:30 AM ET

Company Participants

Sanj Patel - Chairman, Chief Executive Officer

Ross Moat - Group Vice President, General Manager

Eben Tessari - Chief Business Officer

Mark Ragosa - Chief Financial Officer

John Paolini - Chief Medical Officer

Rachel Frank - Associate Director, Investor Relations

Conference Call Participants

Anupam Rama - JP Morgan

Paul Choi - Goldman Sachs

Jason - Bank of America

David Nierengarten - Wedbush

Liisa Bayko - Evercore


Good day and thank you for standing by. Welcome to the Kiniksa Pharmaceuticals third quarter conference call.

At this time, all participants are on a listen-only mode. After the speakers’ presentation, there will be a question and answer session. To ask a question during that session, you will need to press star, one on your telephone. If you require any assistance during the call, please press star, zero.

I would now like to hand the conference over to your speaker today, Ms. Rachel Frank. Ms. Frank, you may begin.

Rachel Frank

Thank you Operator. Good morning everyone and thank you for joining Kiniksa’s call to discuss our third quarter 2021 financial results and our recent corporate and pipeline activity. A press release highlighting these results can be found on our website under the Investors and Media section.

As to the agenda, our Chief Executive Officer, Sanj K. Patel will start with an introduction. Ross Moat, our Head of Commercial will provide an update on the Arcalyst commercial launch; Eben Tessari, Kiniksa’s Chief Business Officer will follow with a brief pipeline review; Mark Ragosa, our Chief Financial Officer will review our third quarter 2021 financial results, and finally Sanj will return for closing remarks and to kick off the Q&A session, for which John Paolini, our Chief Medical Officer will also be on the line.

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About KNSA

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on KNSA

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.